Lataa...
Pharmacokinetics of Rytary(®), An Extended-Release Capsule Formulation of Carbidopa–Levodopa
Parkinson’s disease (PD) is a chronic progressive neurological disorder characterized by resting tremor, rigidity, bradykinesia, gait disturbance, and postural instability. Levodopa, the precursor to dopamine, coadministered with carbidopa or benserazide, aromatic amino acid decarboxylase inhibitors...
Tallennettuna:
| Julkaisussa: | Clin Pharmacokinet |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5563351/ https://ncbi.nlm.nih.gov/pubmed/28236251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40262-017-0511-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|